{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:32:42Z","timestamp":1789637562247,"version":"4.0.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-026-01694-4","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T04:34:41Z","timestamp":1780115681000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Proxied therapeutic inhibition on sclerostin and atrial fibrillation risk"],"prefix":"10.1038","volume":"6","author":[{"given":"Yu","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5603-2012","authenticated-orcid":false,"given":"Peng-Lin","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Yu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0115-8710","authenticated-orcid":false,"given":"Saber","family":"Khederzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Piao","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mo-Chang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Hua","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Da","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8826-0530","authenticated-orcid":false,"given":"David","family":"Karasik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6233-9144","authenticated-orcid":false,"given":"Ching-Lung","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8530-0923","authenticated-orcid":false,"given":"Chao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5681-8598","authenticated-orcid":false,"given":"Hou-Feng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"key":"1694_CR1","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S0140-6736(18)32112-3","volume":"393","author":"JE Compston","year":"2019","unstructured":"Compston, J. E., McClung, M. R. & Leslie, W. D. Osteoporosis. Lancet 393, 364\u2013376 (2019).","journal-title":"Lancet"},{"key":"1694_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-013-0136-1","volume":"8","author":"E Hernlund","year":"2013","unstructured":"Hernlund, E. et al. Osteoporosis in the European Union: Medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch. Osteoporos. 8, 136 (2013).","journal-title":"Arch. Osteoporos."},{"key":"1694_CR3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1080\/13697137.2017.1289659","volume":"20","author":"TJ de Villiers","year":"2017","unstructured":"de Villiers, T. J. The quest for new drugs to prevent osteoporosis-related fractures. Climacteric 20, 103\u2013106 (2017).","journal-title":"Climacteric"},{"key":"1694_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/ng.284","volume":"41","author":"U Styrkarsdottir","year":"2009","unstructured":"Styrkarsdottir, U. et al. New sequence variants associated with bone mineral density. Nat. Genet 41, 15\u201317 (2009).","journal-title":"Nat. Genet"},{"key":"1694_CR5","doi-asserted-by":"publisher","first-page":"e1002745","DOI":"10.1371\/journal.pgen.1002745","volume":"8","author":"HF Zheng","year":"2012","unstructured":"Zheng, H. F. et al. WNT16 influences bone mineral density, cortical bone thickness, bone strength, and osteoporotic fracture risk. PLoS Genet 8, e1002745 (2012).","journal-title":"PLoS Genet"},{"key":"1694_CR6","doi-asserted-by":"publisher","first-page":"E2197","DOI":"10.1073\/pnas.1120407109","volume":"109","author":"Z Zhong","year":"2012","unstructured":"Zhong, Z. et al. Wntless functions in mature osteoblasts to regulate bone mass. Proc. Natl. Acad. Sci. USA 109, E2197\u2013E2204 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1694_CR7","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41392-021-00701-5","volume":"6","author":"F Yu","year":"2021","unstructured":"Yu, F. et al. Wnt\/beta-catenin signaling in cancers and targeted therapies. Signal Transduct. Target Ther. 6, 307 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"1694_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41413-021-00143-3","volume":"9","author":"X Zhu","year":"2021","unstructured":"Zhu, X., Bai, W. & Zheng, H. Twelve years of GWAS discoveries for osteoporosis and related traits: advances, challenges and applications. Bone Res 9, 23 (2021).","journal-title":"Bone Res"},{"key":"1694_CR9","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1086\/318811","volume":"68","author":"ME Brunkow","year":"2001","unstructured":"Brunkow, M. E. et al. Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am. J. Hum. Genet 68, 577\u2013589 (2001).","journal-title":"Am. J. Hum. Genet"},{"key":"1694_CR10","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/hmg\/10.5.537","volume":"10","author":"W Balemans","year":"2001","unstructured":"Balemans, W. et al. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum. Mol. Genet 10, 537\u2013543 (2001).","journal-title":"Hum. Mol. Genet"},{"key":"1694_CR11","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1056\/NEJMe1711298","volume":"377","author":"CJ Rosen","year":"2017","unstructured":"Rosen, C. J. Romosozumab - Promising or practice changing? N. Engl. J. Med. 377, 1479\u20131480 (2017).","journal-title":"N. Engl. J. Med."},{"key":"1694_CR12","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/jbmr.2351","volume":"30","author":"RR Recker","year":"2015","unstructured":"Recker, R. R. et al. A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density. J. Bone Min. Res. 30, 216\u2013224 (2015).","journal-title":"J. Bone Min. Res"},{"key":"1694_CR13","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1056\/NEJMoa1305224","volume":"370","author":"MR McClung","year":"2014","unstructured":"McClung, M. R. et al. Romosozumab in postmenopausal women with low bone mineral density. N. Engl. J. Med. 370, 412\u2013420 (2014).","journal-title":"N. Engl. J. Med."},{"key":"1694_CR14","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","volume":"375","author":"F Cosman","year":"2016","unstructured":"Cosman, F. et al. Romosozumab treatment in postmenopausal women with osteoporosis. N. Engl. J. Med. 375, 1532\u20131543 (2016).","journal-title":"N. Engl. J. Med"},{"key":"1694_CR15","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.bone.2017.07.005","volume":"103","author":"H Ishibashi","year":"2017","unstructured":"Ishibashi, H. et al. Romosozumab increases bone mineral density in postmenopausal Japanese women with osteoporosis: A phase 2 study. Bone 103, 209\u2013215 (2017).","journal-title":"Bone"},{"key":"1694_CR16","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/S0140-6736(17)31613-6","volume":"390","author":"BL Langdahl","year":"2017","unstructured":"Langdahl, B. L. et al. Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial. Lancet 390, 1585\u20131594 (2017).","journal-title":"Lancet"},{"key":"1694_CR17","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","volume":"377","author":"KG Saag","year":"2017","unstructured":"Saag, K. G. et al. Romosozumab or alendronate for fracture prevention in women with osteoporosis. N. Engl. J. Med. 377, 1417\u20131427 (2017).","journal-title":"N. Engl. J. Med"},{"key":"1694_CR18","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1210\/jc.2017-02163","volume":"103","author":"EM Lewiecki","year":"2018","unstructured":"Lewiecki, E. M. et al. A phase III randomized placebo-controlled trial to evaluate efficacy and safety of romosozumab in men with osteoporosis. J. Clin. Endocrinol. Metab. 103, 3183\u20133193 (2018).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1694_CR19","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3803\/EnM.2020.848","volume":"36","author":"KH Baek","year":"2021","unstructured":"Baek, K. H. et al. Romosozumab in postmenopausal Korean women with osteoporosis: A randomized, double-blind, placebo-controlled efficacy and safety study. Endocrinol. Metab. (Seoul.) 36, 60\u201369 (2021).","journal-title":"Endocrinol. Metab. (Seoul.)"},{"key":"1694_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2019.115121","volume":"130","author":"F Lv","year":"2020","unstructured":"Lv, F. et al. Denosumab or romosozumab therapy and risk of cardiovascular events in patients with primary osteoporosis: Systematic review and meta- analysis. Bone 130, 115121 (2020).","journal-title":"Bone"},{"key":"1694_CR21","unstructured":"Evenity: Pending EC decision [https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/evenity]."},{"key":"1694_CR22","unstructured":"https:\/\/www.amgen.com\/newsroom\/press-releases\/2019\/12\/european-commission-approves-evenity-romosozumab-for-the-treatment-of-severe-osteoporosis-in-postmenopausal-women-at-high-risk-of-fracture European Commission approves EVENITY\u00ae (romosozumab) for the treatment of severe osteoporosis in postmenopausal women at high risk of fracture."},{"key":"1694_CR23","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nrd4051","volume":"12","author":"RM Plenge","year":"2013","unstructured":"Plenge, R. M., Scolnick, E. M. & Altshuler, D. Validating therapeutic targets through human genetics. Nat. Rev. Drug Discov. 12, 581\u2013594 (2013).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1694_CR24","unstructured":"Bovijn, J. et al. Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics. Sci. Transl. Med. 12, eaay6570 (2020)."},{"key":"1694_CR25","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1210\/clinem\/dgab193","volume":"106","author":"BL Langdahl","year":"2021","unstructured":"Langdahl, B. L., Hofbauer, L. C. & Forfar, J. C. Cardiovascular safety and sclerostin inhibition. J. Clin. Endocrinol. Metab. 106, 1845\u20131853 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1694_CR26","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","volume":"53","author":"E Ferkingstad","year":"2021","unstructured":"Ferkingstad, E. et al. Large-scale integration of the plasma proteome with genetics and disease. Nat. Genet 53, 1712\u20131721 (2021).","journal-title":"Nat. Genet"},{"key":"1694_CR27","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1136\/annrheumdis-2020-217892","volume":"79","author":"J Xia","year":"2020","unstructured":"Xia, J. et al. Systemic evaluation of the relationship between psoriasis, psoriatic arthritis and osteoporosis: observational and Mendelian randomisation study. Ann. Rheum. Dis. 79, 1460\u20131467 (2020).","journal-title":"Ann. Rheum. Dis."},{"key":"1694_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115247","volume":"133","author":"WY Bai","year":"2020","unstructured":"Bai, W. Y. et al. Identification of PIEZO1 polymorphisms for human bone mineral density. Bone 133, 115247 (2020).","journal-title":"Bone"},{"key":"1694_CR29","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203\u2013209 (2018).","journal-title":"Nature"},{"key":"1694_CR30","doi-asserted-by":"crossref","unstructured":"Bai, W. Y. et al. Genotype imputation and reference panel: A systematic evaluation on haplotype size and diversity. Brief Bioinform. 21,1806\u20131817 (2020).","DOI":"10.1093\/bib\/bbz108"},{"key":"1694_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13690-5","volume":"11","author":"S Shah","year":"2020","unstructured":"Shah, S. et al. Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure. Nat. Commun. 11, 163 (2020).","journal-title":"Nat. Commun."},{"key":"1694_CR32","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/s41588-018-0171-3","volume":"50","author":"JB Nielsen","year":"2018","unstructured":"Nielsen, J. B. et al. Biobank-driven genomic discovery yields new insight into atrial fibrillation biology. Nat. Genet\u00a050, 1234\u20131239 (2018).","journal-title":"Nat. Genet"},{"key":"1694_CR33","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1038\/ng.3913","volume":"49","author":"CP Nelson","year":"2017","unstructured":"Nelson, C. P. et al. Association analyses based on false discovery rate implicate new loci for coronary artery disease. Nat. Genet\u00a049, 1385\u20131391 (2017).","journal-title":"Nat. Genet"},{"key":"1694_CR34","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41588-018-0058-3","volume":"50","author":"R Malik","year":"2018","unstructured":"Malik, R. et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat. Genet 50, 524\u2013537 (2018).","journal-title":"Nat. Genet"},{"key":"1694_CR35","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1126\/science.1262110","volume":"348","author":"GT Consortium","year":"2015","unstructured":"Consortium, G. T. Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science\u00a0348, 648\u2013660 (2015).","journal-title":"Science"},{"key":"1694_CR36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00439-019-02060-2","volume":"139","author":"OB Smeland","year":"2020","unstructured":"Smeland, O. B. et al. Discovery of shared genomic loci using the conditional false discovery rate approach. Hum. Genet 139, 85\u201394 (2020).","journal-title":"Hum. Genet"},{"key":"1694_CR37","doi-asserted-by":"publisher","first-page":"e1004383","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei, C. et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet 10, e1004383 (2014).","journal-title":"PLoS Genet"},{"key":"1694_CR38","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ng.3538","volume":"48","author":"Z Zhu","year":"2016","unstructured":"Zhu, Z. et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat. Genet 48, 481\u2013487 (2016).","journal-title":"Nat. Genet"},{"key":"1694_CR39","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/gepi.22077","volume":"41","author":"S Burgess","year":"2017","unstructured":"Burgess, S., Zuber, V., Valdes-Marquez, E., Sun, B. B. & Hopewell, J. C. Mendelian randomization with fine-mapped genetic data: Choosing from large numbers of correlated instrumental variables. Genet Epidemiol. 41, 714\u2013725 (2017).","journal-title":"Genet Epidemiol."},{"key":"1694_CR40","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden, J., Davey Smith, G., Haycock, P. C. & Burgess, S. Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 40, 304\u2013314 (2016).","journal-title":"Genet Epidemiol."},{"key":"1694_CR41","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden, J., Davey Smith, G. & Burgess, S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J. Epidemiol. 44, 512\u2013525 (2015).","journal-title":"Int J. Epidemiol."},{"key":"1694_CR42","doi-asserted-by":"publisher","first-page":"252","DOI":"10.12688\/wellcomeopenres.16374.2","volume":"5","author":"JR Broadbent","year":"2020","unstructured":"Broadbent, J. R. et al. MendelianRandomization v0.5.0: Updates to an R package for performing Mendelian randomization analyses using summarized data. Wellcome Open Res. 5, 252 (2020).","journal-title":"Wellcome Open Res."},{"key":"1694_CR43","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg3983","volume":"15","author":"C Zheng","year":"2023","unstructured":"Zheng, C. et al. Targeting sulfation-dependent mechanoreciprocity between matrix and osteoblasts to mitigate bone loss. Sci. Transl. Med. 15, eadg3983 (2023).","journal-title":"Sci. Transl. Med."},{"key":"1694_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30184-z","volume":"13","author":"HM Tanha","year":"2022","unstructured":"Tanha, H. M. International Headache Genetics C, Nyholt DR: Genetic analyses identify pleiotropy and causality for blood proteins and highlight Wnt\/beta-catenin signalling in migraine. Nat. Commun. 13, 2593 (2022).","journal-title":"Nat. Commun."},{"key":"1694_CR45","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1016\/j.ajhg.2021.09.011","volume":"108","author":"HM Tanha","year":"2021","unstructured":"Tanha, H. M. & Sathyanarayanan, A. International Headache Genetics C, Nyholt DR: Genetic overlap and causality between blood metabolites and migraine. Am. J. Hum. Genet 108, 2086\u20132098 (2021).","journal-title":"Am. J. Hum. Genet"},{"key":"1694_CR46","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/ije\/dyq151","volume":"40","author":"BL Pierce","year":"2011","unstructured":"Pierce, B. L., Ahsan, H. & Vanderweele, T. J. Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int J. Epidemiol. 40, 740\u2013752 (2011).","journal-title":"Int J. Epidemiol."},{"key":"1694_CR47","volume":"15","author":"KA Alnaqbi","year":"2023","unstructured":"Alnaqbi, K. A., Al Zeyoudi, J. & Aljaberi, A. K. Cardiac Arrhythmia and Heart Failure Shortly After Starting Romosozumab for Osteoporosis: A Case-Based Review. Cureus 15, e50303 (2023).","journal-title":"Cureus"},{"key":"1694_CR48","doi-asserted-by":"crossref","unstructured":"Martinez, S., Anez, D. & Shahid, M. Is atrial fibrillation an adverse cardiovascular effect of romosozumab. J. Endocrine Soc. 8, bvae163.449 (2024).","DOI":"10.1210\/jendso\/bvae163.449"},{"key":"1694_CR49","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/MOL.0000000000000445","volume":"28","author":"A Gay","year":"2017","unstructured":"Gay, A. & Towler, D. A. Wnt signaling in cardiovascular disease: opportunities and challenges. Curr. Opin. Lipido 28, 387\u2013396 (2017).","journal-title":"Curr. Opin. Lipido"},{"key":"1694_CR50","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1124\/pr.117.013896","volume":"70","author":"S Foulquier","year":"2018","unstructured":"Foulquier, S. et al. WNT signaling in cardiac and vascular disease. Pharm. Rev. 70, 68\u2013141 (2018).","journal-title":"Pharm. Rev."},{"key":"1694_CR51","doi-asserted-by":"crossref","unstructured":"Catalano, A., Bellone, F., Morabito, N., Corica, F. Sclerostin and vascular pathophysiology. Int. J. Mol. Sci. 21 (2020).","DOI":"10.3390\/ijms21134779"},{"key":"1694_CR52","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1093\/europace\/euaa030","volume":"22","author":"KE Kristensen","year":"2020","unstructured":"Kristensen, K. E. et al. Subclinical atherosclerosis is associated with incident atrial fibrillation: A systematic review and meta-analysis. Europace\u00a022, 991\u20131000 (2020).","journal-title":"Europace"},{"key":"1694_CR53","doi-asserted-by":"crossref","unstructured":"O\u2019Neal, W. T. et al. Coronary artery calcium progression and atrial fibrillation: The multi-ethnic study of atherosclerosis. Circ. Cardiovasc. Imaging. 8, e003786 (2015).","DOI":"10.1161\/CIRCIMAGING.115.003786"},{"key":"1694_CR54","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.3389\/fphys.2018.01380","volume":"9","author":"NC Denham","year":"2018","unstructured":"Denham, N. C. et al. Calcium in the pathophysiology of atrial fibrillation and heart failure. Front Physiol. 9, 1380 (2018).","journal-title":"Front Physiol."},{"key":"1694_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2025.102988","volume":"50","author":"Y Chang","year":"2025","unstructured":"Chang, Y. & Zou, Q. Mitochondrial calcium homeostasis and atrial fibrillation: Mechanisms and therapeutic strategies review. Curr. Probl. Cardiol. 50, 102988 (2025).","journal-title":"Curr. Probl. Cardiol."},{"key":"1694_CR56","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.advms.2017.06.005","volume":"63","author":"E Michniewicz","year":"2018","unstructured":"Michniewicz, E., Mlodawska, E., Lopatowska, P., Tomaszuk-Kazberuk, A. & Malyszko, J. Patients with atrial fibrillation and coronary artery disease - Double trouble. Adv. Med Sci. 63, 30\u201335 (2018).","journal-title":"Adv. Med Sci."},{"key":"1694_CR57","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1001\/jama.2014.9143","volume":"312","author":"G Gialdini","year":"2014","unstructured":"Gialdini, G. et al. Perioperative atrial fibrillation and the long-term risk of ischemic stroke. JAMA 312, 616\u2013622 (2014).","journal-title":"JAMA"},{"key":"1694_CR58","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1177\/2047487317715769","volume":"24","author":"V Ruddox","year":"2017","unstructured":"Ruddox, V. et al. Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis. Eur. J. Prev. Cardiol. 24, 1555\u20131566 (2017).","journal-title":"Eur. J. Prev. Cardiol."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01694-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01694-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01694-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:00:10Z","timestamp":1787698810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-026-01694-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1694"],"URL":"https:\/\/doi.org\/10.1038\/s43856-026-01694-4","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"18 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"461"}}